Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 May 2023 | Story Dr Cornelius Hagenmeier | Photo Barend Nagel
Africa Month
Inspired by its commitment to Africa, the UFS celebrates Africa Month annually, under the motto ‘One Africa together forever'.

Click to view document#AfricaDay2023: ‘Africa is not a country, it’s a vast tapestry of innumerable stories’


A focus on the African continent is central to the University of the Free State’s (UFS) internationalisation strategy, which envisages an Africa-imbued internationalisation process that advances Africanisation and decolonisation, and includes a focus on expanding researcher networks across Africa.

The UFS considers internationalisation, Africanisation, and decolonisation as complementary processes, and prioritises engagements with the Southern African Development Community (SADC) and African countries. The university’s Vision 130 emphasises the UFS’s commitment to the development of the African continent

One Africa together forever

Inspired by its commitment to Africa, the UFS celebrates Africa Month annually, under the motto ‘One Africa together forever'. Every year the campaign focuses on a different theme – this year, it is 'Promoting and appreciating knowledge in and from Africa'. This follows 'Celebrating African Education as a Conduit for African Unity’ in 2022 and ‘Solidarity in Knowledge Production and Recording’ in 2021. The diverse contributions from members of the UFS community, including all celebrations since 2019, are available from the Africa Month section of the UFS website.

The university's internationalisation strategy commits the UFS to co-creating knowledge across the African continent. Manifold collaborations with African universities underpin this. The number of scientific publications co-authored with colleagues across Africa is growing steadily. Between 2019 and 2022, UFS researchers collaborated with 381 African institutions, which resulted in 3 002 co-authored publications.

Strengthening formal partnerships with African universities is an important aspect of the UFS focus on Africa. This presently includes the University of Botswana, the University of Namibia, the National University of Lesotho, Niger Delta University, and the University of Ibadan in Nigeria. In an opinion piece published on the 2023 UFS Africa Month website, Prof Hussein Solomon of the UFS’s Centre for Gender and Africa Studies shares that “any memorandum of understanding needs to deliver on tangible outputs” and cites the example of a collaboratively edited book which he champions together with his Niger Delta University colleague Prof Jude Cocodia.

Flags of Africa

Developing partnerships on the continent

The university invests in strengthening existing and establishing new collaborations on the African continent. In 2022, it focused on developing new partnerships in Ghana and Gabon. In Ghana, it was possible to leverage existing collaborations championed by Prof Loyiso Jita, Dean of the UFS Faculty of Education, to establish institutional collaboration with the University of the Cape Coast and formalise the relationship with the University of Ghana. In Uganda, the UFS established a new collaboration with Busitema University, which is championed by Prof Motlalepula Matsabisa from the Faculty of Health Sciences.

New partnerships were initiated with three Gabonese higher education institutions, including the International Centre for Medical Research in Franceville (CIRMF). The institution's Director-General, Prof Jean Bernard Lekana-Douki, and the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen, signed a memorandum of understanding in April 2023.

Collaboration had already commenced with a visit by the CIRMF's Dr Judicaël Obame to the UFS Department of Zoology and Entomology in December 2022, during which he delivered a guest lecture and conducted a workshop on mosquito rearing. The targeted engagement with Gabon also resulted in a delegation from École de Management du Gabon University (EM-Gabon) led by its President, Prof Daniel Idiata, visiting the UFS in November 2022 and subsequently formalising its collaboration with the UFS. Together with the Masuku University of Science and Technology, also located in Gabon, PhD co-supervision commenced as a result of the new partnership.

Qwaqwa-campus-based Dr Patricks Otomo, who champions the collaboration and serves as the campus Subject Head: Zoology and Entomology, explains: “As a student in Gabon in the early 2000s, I benefited from an agreement between the Masuku University of Science and Technology, where I was an undergraduate student at the time, and Stellenbosch University. This agreement allowed me to further my studies in South Africa, eventually earning my honours, master’s, and PhD at Stellenbosch University. Knowing the benefits of such agreements and the potential for internationalisation at the UFS, two years ago I approached the Vice-Rector for Research and Internationalisation, Prof Corli Witthuhn, with the idea of intensifying the UFS collaboration with my home country, Gabon. Together with Prof Witthuhn and Dr Cornelius Hagenmeier, Director of the UFS Office for International Affairs, we visited three higher education institutions in the country. We explored collaboration with a specific focus on PhD education. The response was overwhelming: in a short period, it was possible to develop lively partnerships with all three institutions.”

One of the UFS’s important regional partners is the National University of Lesotho. Prof Petersen visited it in 2022 to strengthen the existing multi-layered collaboration, which is underpinned by a memorandum of understanding. Joint activities are taking place through the Directorate for Research Development, which coordinates the Lesotho Highlands Water Project; the Faculty of Education, the Departments of Pharmacology, Political Studies, and Africa Studies; and the Afromontane Research Unit on the UFS Qwaqwa Campus.

Flags of Africa

Connecting the UFS to African philosophy and knowledge paradigms

UFS academics are constantly at the forefront of producing and disseminating cutting-edge work on the African continent. During Africa Month, the UFS, in partnership with Sweden’s Karolinska Institutet, hosted the first Crimean-Congo haemorrhagic fever virus (CCHFV) Africa Conference, at which experts from 16 countries – including 12 African countries – deliberated on CCHFV. It was co-organised by Prof Felicity Burt, an expert in arbovirology from the UFS’s Division of Virology in the Faculty of Health Sciences.

Another example of the UFS's research leadership in Africa is that Prof Martin Nyaga, Head of the UFS Next Generation Sequencing (UFS-NGS) Unit, chairs the Africa Centre for Communicable and Preventable Diseases (Africa CDC) working group on Vaccine Preventable Diseases (VPD). Meanwhile, research collaboration in the Humanities is also flourishing. For example, Prof Chitja Twala, Vice-Dean in the Faculty of the Humanities, has a long-standing relationship with the University of Ghana’s Department of History, and travelled to the partner university in 2022 for an extended research visit.

The UFS is also engaged in many African university networks, which ensures that the university is part of contemporary African higher education discourses. For example, the UFS is an active member of the Association of African Universities (AAU), the Southern African Regional Universities Association (SARUA), and the Regional Universities Forum for Capacity Building in Agriculture (RUFORUM) .

Through its manifold African collaborations, the UFS lives up to the commitment expressed in its internationalisation strategy: to connect the UFS to African philosophy and knowledge paradigms. Moreover, the UFS’s engagements throughout Africa ensure that the university contributes significantly to promoting and appreciating knowledge in and from Africa.

UFS Rector and Vice Chancellor Prof Francis Petersen summarised this poignantly during the 2022 UFS Africa Month: “Our engagement with the world needs to ensure that the knowledge emanating from our university, our country, and our continent is shared globally.”

The UFS’s collaborations with institutions across Africa make a significant contribution in this regard.

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept